A Clinical Study to Assess the Efficacy and Safety of Three Doses of Vildagliptin in Patients With Type 2 Diabetes
Clinical trial NCT00099905 · COMPLETED
Trial details
- NCT number
- NCT00099905
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2004-04-01
- Primary completion
- 2005-10-01
- Enrollment
- 639
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.